Skip to main content

Parallel Advisors, LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in DNLI

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$5,478
-$1,395 QoQ
Shares Held
213
-40.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#242
of 290 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. DNLI ranks #86 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,478 213
2026-03-31 $6,873 358
2025-12-31 $5,910 358
2025-09-30 $6,301 434
2025-06-30 $7,624 545
2025-03-31 $2,202 162
2024-12-31 $2,017 99
2024-09-30 $3,262 112
2024-06-30 $2,600 112
2024-03-31 $8,536 416
2023-12-31 $1,781 83
2022-09-30 $306 10
2022-06-30 $294 10
2022-03-31 $64 2
2021-12-31 $2,051 46
2021-03-31 $685 12
2020-12-31 $1,005 12